Dr. Soror, a gradating fellow who just started her first year as an attending, shares with all what she wished she had known when she started her fellowship. Every Heme/Onc fellow must listen to this one.

Dr. Yelena Janjigian of Memorial Sloan Kettering Cancer Center joins the Healthcare Unfiltered Express to provide a timely and concise overview on how best to treat upper GI Cancers. So much data on IO in upper GI cancers and more to come at ESMO 2025; take a listen to this timely podcast, subscribe, share, and join the conversation.

Lots of changes in managing advanced Hodgkin lymphoma especially with recent SWOG1826 data. Dr. Ann LaCasce provides an overview with excellent clinical pearls on how to approach this curabe malignancy.

Dr. Rana McKay visits the Healthcare Unfiltered EXPRESS to share her insights of how best to treat clear cell renal cell carcinoma - perfect listen ahead of the ESMO 2025 meeting happening this week as more GU oncology data emerges.

Please subscribe, share, and join the conversation.

Dr. Halmos from Montefiore in New York shares his views on the most impactful practice changing or informing data for lung cancer from the ASCO 2025 meeting.

Dr. Andrea Apolo from the NCI and world-renowned GU oncologist joins the Healthcare Unfiltered EXPRESS to share her insights on how best to manage urothelial cancers in view of so much new data and in anticipation of the ESMO-2025 data expected soon.

Dr. Rajkumar from the Mayo Clinic explains why many have been disappointed by the ODAC decision to recommend not approving Benrep for relapsed/refractory multiple myeloma. Thought provoking. This was taped live while we broadcasted on Twitter Spaces on 7/22/2025.

Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.